Gabapentin Capsules, USP, 100 mg, 10 capsules (10x1) per bag, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN, 46268 USA, Distributed by Cardinal Health, Dublin, OH 43017, NDC 55154-3363-0
Published July 9, 2025 · Recall initiated: June 19, 2025
Summary
FDA records drug Class II recall D-0508-2025, published July 9, 2025 and initiated June 19, 2025. Recalling firm: The Harvard Drug Group LLC; Status: Ongoing; Reported quantity: 3,527 bags; Lot: Lot# M05205A and M05205B, Exp Date 10/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective container; blister packaging inadequately sealed.
What to do
Voluntary: Firm initiated · Letter
Get an email if GABAPENTIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- GABAPENTIN
- Manufacturer
- The Harvard Drug Group LLC
- Distributor
- Nationwide
- UPC
- 0055154336307
- Lot
- Lot# M05205A and M05205B, Exp Date 10/2026.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAGabapentin Capsules, USP, 100 mg, 10 Capsules (10 x 1 blister pack), Rx only, Packaged and Distributed by:October 29, 2025
- FDAGabapentin Capsules, USP, 100 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by:October 29, 2025
- FDAGabapentin Capsules, USP, 100 mg, 100 capsules (10x10), blister pack cartons, Rx only, Packaged andJuly 9, 2025
- FDAMetoprolol Succinate Extended-Release Tablets, USP, 25 mg, Packaged in a) 100-count bottle, NDC 70010-780-01;July 9, 2025
- FDAOrajel Baby, Cooling Swabs for Teething, Each Unit 0.007 fl oz (0.22 mL), NET 0.08 FL OZ (2.6 mL) TOTAL, 12July 9, 2025
- FDAGabapentin Capsules, USP 400 mg, Rx Only, Packaged in a) 500-count bottles, NDC 62756-139-05; b) 1000-countApril 16, 2025
Questions about this recall
Was Gabapentin Capsules, USP, 100 mg, 10 capsules (10x1) per bag, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN, 46268 USA, Distributed by Cardinal Health, Dublin, OH 43017, NDC 55154-3363-0 recalled?
Yes. FDA published recall D-0508-2025 on July 9, 2025. Reported hazard: Defective container; blister packaging inadequately sealed.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: GABAPENTIN. UPC: 0055154336307.